Phoenix Financial recently acquired more than 3.5 million additional shares of Teva Pharmaceutical Industries in the third ...

Teva Pharmaceutical Industries TEVA reported third-quarter 2025 adjusted earnings of 78 cents per share, which beat the Zacks ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

Teva Pharmaceutical Industries Ltd. stock rose 12% after the company reported stronger-than-expected third-quarter results, buoyed by robust growth in its branded drug portfolio. The Tel Aviv-based ...

Teva has issued a voluntary recall of more than 500,000 bottles of the widely used blood pressure medication prazosin ...

For an accessible version of this Press Release, please visit Teva reports revenues of $4.5 billion in the third quarter of ...

Explore how Teva Pharmaceutical (NYSE:TEVA) strengthens its global presence and influence in Healthcare Stocks worldwide.

Management reported that the terms of the license and supply agreement show that Teva Pharmaceutical Industries Limited (NYSE ...

Teva Pharmaceutical (TEVA) stock surges as the company posts better than expected Q3 2025 results and raises the midpoint of ...

Teva’s key innovative brands portfolio, which includes AUSTEDO, AJOVY, and UZEDY, continued to drive growth with revenues increasing 33% YoY in local currency to $830 million. AUSTEDO led the way with ...

TEL AVIV, Feb 13 (Reuters) - Teva Pharmaceutical Industries Ltd. said on Tuesday that fourth-quarter net earnings rose, helped by sales of new products in the United States and its acquisition of IVAX ...